GlassScriptPhysician profile
Sandip Steven Chander
NPI 1407952781
$6,612.36
in general payments reported to CMS, 2019-2025
25 companies · $826 in 2025
The $826 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $479 · 2021: $2,133 · 2022: $707 · 2023: $912 · 2024: $1,079 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,509 · Gift: $175 · Entertainment: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,509.02 |
| Gift | $175.00 |
| Entertainment | $133.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $1,729.82 | 2019-2022 | |
| Alcon Vision LLC | $1,342.36 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $721.86 | 2023-2025 | Infuse, Miebo, Biotrue One Day |
| Tarsus Pharmaceuticals, INC. | $546.43 | 2024-2025 | Xdemvy |
| Coopervision INC. | $356.78 | 2021-2025 | Cvi Contact Lens, Myday Contact Lens, Synergeyes Contact Lens |
| Abb Con-Cise Optical Group LLC | $242.70 | 2021-2025 | Contact Lens, Spectacle Lenses |
| Dompe US, INC. | $224.19 | 2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $210.18 | 2019-2021 | |
| Visionary Optics LLC | $175.00 | 2023 | |
| Biotissue Holdings INC. | $150.07 | 2023-2024 | |
| Abbvie INC. | $135.80 | 2022 | |
| Sight Sciences, INC. | $134.35 | 2019-2023 | Tearcare System |
| Optos, INC. | $133.60 | 2024-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Surgical Vision, INC. | $101.69 | 2021-2023 | Tecnis Iol |
| Allergan, INC. | $76.78 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $69.32 | 2024 | Istent Infinite Trabecular Micro Bypass System, Idose |
| Visioneering Technologies, INC. | $42.68 | 2019-2021 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Ivantis, INC | $35.91 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $35.85 | 2023 | Acuvue |
| Rayner Intraocular Lenses Limited | $34.51 | 2024 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Iridex Corporation | $20.75 | 2021 | |
| Shire North American Group INC | $19.60 | 2019 | |
| Tearlab Corp | $17.59 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandip Chander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.